161 related articles for article (PubMed ID: 32065406)
1. Surgery versus Imaging in Non-Localizing Primary Hyperparathyroidism: A Cost-Effectiveness Model.
Frank E; Watson W; Fujimoto S; De Andrade Filho P; Inman J; Simental A
Laryngoscope; 2020 Dec; 130(12):E963-E969. PubMed ID: 32065406
[TBL] [Abstract][Full Text] [Related]
2. The cost-effectiveness of additional preoperative ultrasonography or sestamibi-SPECT in patients with primary hyperparathyroidism and negative findings on sestamibi scans.
Ruda JM; Stack BC; Hollenbeak CS
Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):46-53. PubMed ID: 16415429
[TBL] [Abstract][Full Text] [Related]
3. Would scan, but which scan? A cost-utility analysis to optimize preoperative imaging for primary hyperparathyroidism.
Wang TS; Cheung K; Farrokhyar F; Roman SA; Sosa JA
Surgery; 2011 Dec; 150(6):1286-94. PubMed ID: 22136852
[TBL] [Abstract][Full Text] [Related]
4. A cost-utility analysis of 18F-fluorocholine-positron emission tomography imaging for localizing primary hyperparathyroidism in the United States.
Yap A; Hope TA; Graves CE; Kluijfhout W; Shen WT; Gosnell JE; Sosa JA; Roman SA; Duh QY; Suh I
Surgery; 2022 Jan; 171(1):55-62. PubMed ID: 34340823
[TBL] [Abstract][Full Text] [Related]
5. Enabling minimal invasive parathyroidectomy for patients with primary hyperparathyroidism using Tc-99m-sestamibi SPECT-CT, ultrasound and first results of (18)F-fluorocholine PET-CT.
Kluijfhout WP; Vorselaars WM; Vriens MR; Borel Rinkes IH; Valk GD; de Keizer B
Eur J Radiol; 2015 Sep; 84(9):1745-51. PubMed ID: 26047823
[TBL] [Abstract][Full Text] [Related]
6. Successful minimally invasive surgery for primary hyperparathyroidism: influence of preoperative imaging and intraoperative parathyroid hormone levels.
Joliat GR; Demartines N; Portmann L; Boubaker A; Matter M
Langenbecks Arch Surg; 2015 Dec; 400(8):937-44. PubMed ID: 26590819
[TBL] [Abstract][Full Text] [Related]
7. Upfront F18-choline PET/CT versus Tc99m-sestaMIBI SPECT/CT guided surgery in primary hyperparathyroidism: the randomized phase III diagnostic trial APACH2.
Quak E; Lasne Cardon A; Ciappuccini R; Lasnon C; Bastit V; Le Henaff V; Lireux B; Foucras G; Jaudet C; Berchi C; Grellard JM; Lequesne J; Clarisse B; Bardet S
BMC Endocr Disord; 2021 Jan; 21(1):3. PubMed ID: 33413316
[TBL] [Abstract][Full Text] [Related]
8. The cost-effectiveness of three strategies for the surgical treatment of symptomatic primary hyperparathyroidism.
Baliski C; Nosyk B; Melck A; Bugis S; Rosenberg F; H Anis A
Ann Surg Oncol; 2008 Oct; 15(10):2653-60. PubMed ID: 18677536
[TBL] [Abstract][Full Text] [Related]
9. A rural perspective on minimally invasive parathyroidectomy: optimal preoperative imaging and patient outcomes.
Binks M; Burrows D; Littlejohn D
ANZ J Surg; 2019 Jan; 89(1-2):43-47. PubMed ID: 29873171
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of scan-directed parathyroidectomy.
Mihai R; Weisters M; Stechman MJ; Gleeson F; Sadler G
Langenbecks Arch Surg; 2008 Sep; 393(5):739-43. PubMed ID: 18670746
[TBL] [Abstract][Full Text] [Related]
11. Localization of parathyroid adenomas by sonography and technetium tc 99m sestamibi single-photon emission computed tomography before minimally invasive parathyroidectomy: are both studies really needed?
Tublin ME; Pryma DA; Yim JH; Ogilvie JB; Mountz JM; Bencherif B; Carty SE
J Ultrasound Med; 2009 Feb; 28(2):183-90. PubMed ID: 19168768
[TBL] [Abstract][Full Text] [Related]
12. A Multimodal Imaging Protocol, (123)I/(99)Tc-Sestamibi, SPECT, and SPECT/CT, in Primary Hyperparathyroidism Adds Limited Benefit for Preoperative Localization.
Lee GS; McKenzie TJ; Mullan BP; Farley DR; Thompson GB; Richards ML
World J Surg; 2016 Mar; 40(3):589-94. PubMed ID: 26732668
[TBL] [Abstract][Full Text] [Related]
13. Outpatient minimally invasive parathyroidectomy: a combination of sestamibi-SPECT localization, cervical block anesthesia, and intraoperative parathyroid hormone assay.
Chen H; Sokoll LJ; Udelsman R
Surgery; 1999 Dec; 126(6):1016-21; discussion 1021-2. PubMed ID: 10598182
[TBL] [Abstract][Full Text] [Related]
14. An algorithm to maximize use of minimally invasive parathyroidectomy.
Quiros RM; Alioto J; Wilhelm SM; Ali A; Prinz RA
Arch Surg; 2004 May; 139(5):501-6; discussion 506-7. PubMed ID: 15136350
[TBL] [Abstract][Full Text] [Related]
15. Value of
Asseeva P; Paladino NC; Guerin C; Castinetti F; Vaillant-Lombard J; Abdullah AE; Farman-Ara B; Loundou A; Sebag F; Taïeb D
Am J Surg; 2019 Jan; 217(1):108-113. PubMed ID: 29980283
[TBL] [Abstract][Full Text] [Related]
16. Outcomes and economic analysis of routine preoperative 4-dimensional CT for surgical intervention in de novo primary hyperparathyroidism: does clinical benefit justify the cost?
Abbott DE; Cantor SB; Grubbs EG; Santora R; Gomez HF; Evans DB; Lee JE; Vu T; Perrier ND
J Am Coll Surg; 2012 Apr; 214(4):629-37; discussion 637-9. PubMed ID: 22321526
[TBL] [Abstract][Full Text] [Related]
17. The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism.
Udelsman R; Lin Z; Donovan P
Ann Surg; 2011 Mar; 253(3):585-91. PubMed ID: 21183844
[TBL] [Abstract][Full Text] [Related]
18. Minimally invasive/focused parathyroidectomy in patients with negative sestamibi scan results.
Kandil E; Malazai AJ; Alrasheedi S; Tufano RP
Arch Otolaryngol Head Neck Surg; 2012 Mar; 138(3):223-5. PubMed ID: 22351855
[TBL] [Abstract][Full Text] [Related]
19. The cost of screening for synchronous thyroid disease in patients presenting with primary hyperparathyroidism.
Hollenbeak CS; Lendel I; Beus KS; Ruda JM; Stack BC
Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1013-21. PubMed ID: 17938325
[TBL] [Abstract][Full Text] [Related]
20. Minimally Invasive Parathyroidectomy Versus Bilateral Neck Exploration for Primary Hyperparathyroidism.
Laird AM; Libutti SK
Surg Oncol Clin N Am; 2016 Jan; 25(1):103-18. PubMed ID: 26610777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
